Abbott Earns FDA Ad Division Letter For Newborn Surfactant Survanta Promotion
This article was originally published in The Pink Sheet Daily
Executive Summary
Ad division charges Abbott's Ross Products with unsubstantiated effectiveness claims in a professional mailer for beractant for respiratory distress in premature infants. The letter also takes issue with presentation of risk information.